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ANALYSIS OF SEGMENTAL MYOCARDIAL FUNCTION AFf-EFI LOAD 
ALTERATION USING MRI TISSUE TAGGING 
C. pm Nathaniel Reichek, Barbara Tallant, Susan B. Yeon, 
Joao Lima, Eric Hoffman, Leon Axel, Hospital of the University of 
Pennsylvania, Philadelphia, Pa. 
EFFECT OF ANGIOTENSIN II ON REGIONAL WALL MOTION 
AND RELAXATION IN INTACT DOGS. 
Toshiro Miura. Valmik Bhargava, Brian D. Guth, Shunichi 
MiyaZakb Ciro tndorfy, Kathorina S. Sunnerhagen, and Kirk L. 
Peterson. 
Magnetic resonance tagging provides a noninvasive method to evaluate 
segmental myocardial function topographically. Using one such 
technique, Spatial Modulation of Magnetization (SPAMM), we have 
demonstrated transmural heterogeneity of segmental myocardial 
shortening in normal human LV. To determine the load dependence of 
segmental shortening heterogeneity, we examined circumferential 
segment shortening (%S) before and after phenylephrine (phenyl) 
infusion in nurmal canine LV using SPAMM. Magnetic resonance 
imaging and high fidelity LV pressure recordings were performed in 6 
sedated adult dogs before and after phenyl infusion, and %S determined 
at anterior, inferior, lateral, and septal regions in endocardial, 
midwall, and epicardial layers on 3-6 slices. Mean basal LV end- 
systolic pressure was 115+13 mmHg before, and 208tlO mmHg after 
phenylephrine. Mean baJaI heart rale was 93tlO before, and 100+12 
after phenyl. 
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Results demonstrated significant global depression of %S after phenyl 
Infusion. However, the normal lransmural gradient was preser\led 
from endocardium to epicardium. Regional differences In %S were nol 
significant. We conclude that despite known (ransmural and repc Cal 
differences in fiber orientation, normal heterogeneity of segmer ) 
shortening is preserved during increased afterload. 
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To assess the effect of increased afterload on left ventricular 
function, left ventricular pressure was measured by Millar catheter 
and its decay rate (Tau) calculated in 7 dogs. Regional wall motion 
was assessed by a new frame-by-frame video-intensity technique 
which correlates regional intensity to global during each 50 msec, 
yielding slope of linear regression, a measure of transient 
asynchrony. Slopes <I are defined as abnormal. At control, 
asynchrony was not detected in any region. After infusion of 
angiotensin II. peak left ventricular pressure increased by 35 mmHg 
with significant increase in Tau (32 & 4 to 39 + 7 msec, peO.005). 
Mean ejection fraction decreased from 46% to 3396 (p<O.Ol). All 
dogs showed early diastolic asynchrony. Five oi seven dispiayed 
diastolic asynchrony in apical region and remdining two in inferior 
region. During early systole, asynchrony was noted in apical region 
in five of seven animals and inferior region in one. Mean slope in 
abnormal regions were -0.32 in early systole and -0.73 in ear!y 
diastole. The corresponding mean values in norm;\. regions were 
2.67 and 3.29. Thus, increased afterload resulted in transient 
asynchrony in both early systole and diastole in intact left ventricle, 
which may contribute in part to slow relaxation estimated by Tau. 
DEHYDROEPI.QNDROSTERONE IN WO AND IN VrrRO INHIBITS 
PLATELET AGGREGATION. 
Robert Jesse, John Nestler, David Eich, Michael Hess, Medical College of 
Vtrginia, Richmond, VA 
Dehydroepiandrosrerone (DHEA) is an endogenous aadrogenic steroid with 
a myriad of physiological effects, including the ability to delay progression of 
atherosclerosis in certain animal models. We hypothesized that a potential 
mechanism for this effect could be through an influence on platelet function. 
Platelet aggregation was studied in titrated plateIet-rich plasma (PRP) by 
turbidimetric techniques. Addition of 3.3 to 10.0 &l DHEA-sulfate (DHEA- 
S) to PRP showed a dose dependent inhibition of arachidonic acid induced 
platelet aggregation which was in part dependent upon the length of time the 
platelets were exposed to DHEA prior to aggregation being initiated by the 
addition of arachidonate. At 3.3 rM DHEA completely inhibited aggregation 
with a preincubation period of 5.0 min., while at 10.0 ti aggregation was 
completely inhibited with pre-incubation Ius than one min. ‘Ibromboxane B 
production declined proportionally lo added DHEA-S: control = %.8 2 6.2 
pg/ml PRP, with 3.3 rM DHEA-S = 46.0 z 4.0, 6.7 UM = 27.3 f 1.1 and 
10 rM = 21.8 2 1.8 p#ml PRP. In a double blind placebo controlled trial, 
male volunteers ages 22 to 37, were given either placebo (n-S), or 300 mg 
of DHEA t.i.d. (n=S), for 14 days. Baseline values for aggregation and 
DHEA/DHEA-S were determined on 3 occasions prior to starting medication. 
These were again tested on days 7, 10, 14, and 30. Four of the 5 patients 
taking DHEA developed a delay in the rate of aggregation or an increase in 
the minimal concentration of arachidonate needed to initiate aggregation; in 
one patient aggregation was completely inhibited. In the fifth Datient there ‘ 
was no change. None of the patients taking placebo had any changes in 
aggregation. Al baseline, serum DHEA was 5.83 + 3.9 ne/ml: levels between 
day 7-14 in the treated group were 28.7 + 13.9, and in’the p!scebo group 
were 5.58 f 4.1 @ml. Serum DHEA-sulfate was 316.20 &dl at baseline, 
and between day 7-14 was 1451.9 f 419.5 in the mated and X0.5 + 
56.7 ugldl in the placebo group. We conclude that increasing serum DHEA 
concentration can affect platelet reactivity, both when added directly to 
platelet rich plasma or when taken orally prior to preparation of PRP. 
